The sensitization of peripheral C-fibers to lysophosphatidic acid in bone cancer pain

Life Sciences

Volumn 87, Issue 3-4, 2010, Pages 120-125

  Zhao, Jun ^a   Pan, Hai Li ^a   Li, Ting Ting ^a   Zhang, Yu Qiu ^a   Wei, Jen Yu ^b   Zhao, Zhi Qi ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone cancer pain; C nociceptor; LPA1 receptor; Lysophosphatidic acid; Sural nerve

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; CAPSAICIN; LYSOPHOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VPC 32183;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CANCER; CANCER CELL CULTURE; CANCER MODEL; CANCER PAIN; CONTROLLED STUDY; DRUG TARGETING; FEMALE; IMMUNOHISTOCHEMISTRY; NERVE FIBER C; NONHUMAN; RAT; SPINAL GANGLION; SURAL NERVE; WESTERN BLOTTING; X RAY;

ANIMALS; BLOTTING, WESTERN; BONE NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HYPERALGESIA; LYSOPHOSPHOLIPIDS; NEOPLASM TRANSPLANTATION; NERVE FIBERS, UNMYELINATED; NEURONS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; SURAL NERVE;

RATTUS;

EID: 77954310586     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.05.015     Document Type: Article

References (42)

1. Ali Z., Ringkamp M., Hartke T.V., Chien H.F., Flavahan N.A., Campbell J.N., Meyer R.A. Uninjured C-fiber nociceptors develop spontaneous activity and alpha-adrenergic sensitivity following L6 spinal nerve ligation in monkey. Journal of Neurophysiology 1999, 81:455-466.
2. Anliker B., Chun J. Cell surface receptors in lysophospholipid signaling. Seminars in Cell & Developmental Biology 2004, 15:457-465.
3. Boucharaba A., Serre C.M., Gres S., Saulnier-Blache J.S., Bordet J.C., Guglielmi J., Clezardin P., Peyruchaud O. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. The Journal of Clinical Investigation 2004, 114:1714-1725.
4. Cang C.L., Zhang H., Zhang Y.Q., Zhao Z.Q., et al. PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons. Molecular Pain 2009, 5:33.
5. Carlton S.M., Du J.H., Tan H.Y., Nesic O., Hargett G.L., Bopp A.C., Yamani A., Lin Q., Willis W.D., Hulsebosch C.E. Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury. Pain 2009, 147:265-276.
6. Djouhri L., Koutsikou S., Fang X., McMullan S., Lawson S.N. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. The Journal of Neuroscience 2006, 26:1281-1292.
7. Elmes S.J., Millns P.J., Smart D., Kendall D.A., Chapman V. Evidence for biological effects of exogenous LPA on rat primary afferent and spinal cord neurons. Brain Research 2004, 1022:205-213.
8. Fang X.J., Schummer M., Mao M.L., Yu S.X., Tabassam F.H., Swaby R., Hasegawa Y., Tanyi J.L., LaPushin R., Eder A., Jaffe R., Erickson J., Mills G.B. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 2002, 1582:257-264.
9. Fukushima N. LPA in neural cell development. Journal of Cellular Biochemistry 2004, 92:993-1003.
10. Guo R., Kasbohm E.A., Arora P., Sample C.J., Baban B., Sud N., Sivashanmugam P., Moniri N.H., Daaka Y. Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells. Endocrinology 2006, 147:4883-4892.
11. Inoue M., Rashid M.H., Fujita R., Contos J.J.A., Chun J., Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Natural Medicines 2004, 10:712-718.
12. Ishdorj G., Graham B.A., Hu X., Chen J., Johnston J.B., Fang X., Gibson S.B. Lysophosphatidic acid (LPA) protected cancer cells from histone deacetylase(HDAC) inhibitor-induced apoptosis through activation of HDAC. The Journal of Biological Chemistry 2008, 283:16818-16829.
13. Kim M.J., Lee Y.S., Han J.K. Modulation of lysophosphatidic acid-induced Cl-currents by protein kinases A and C in the Xenopus oocyte. Biochemical Pharmacology 2000, 59:241-247.
14. Lee C.W., Rivera R., Gardell S., Dubin A.E., Chun J. GPR92 as a new G(12/13)- and G(q)-coupled lysophosphatidic acid receptor that increases cAMP, LPA(5). The Journal of Biological Chemistry 2006, 281:23589-23597.
15. Lee W.S., Hong M.P., Kim T.H., Shin Y.K., Lee C.S., Park M., Song J.H. Effects of lysophosphatidic acid on sodium currents in rat dorsal root ganglion neurons. Brain Research 2005, 1035:100-104.
16. Li H.S., Zhao Z.Q. Small sensory neurons in the rat dorsal root ganglia express functional NK-1 tachykinin receptor. The European Journal of Neuroscience 1998, 10:1292-1299.
17. Mantyh P.W., Clohisy D.R., Koltzenburg M., Hunt S.P. Molecular mechanisms of cancer pain. Nature Reviews. Cancer 2002, 2:201-209.
18. Mao-Ying Q.L., Zhao J., Dong Z.Q., Wang J., Yu J., Yan M.F., Zhang Y.Q., Wu G.C., Wang Y.Q. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochemical and Biophysical Research Communications 2006, 345:1292-1298.
19. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997, 69:1-18.
20. Mercadante S., Arcuri E. Breakthrough pain in cancer patients: pathophysology and treatment. Cancer Treatment Reviews 1998, 24:425-432.
21. Niiyama Y., Kawamata T., Yamamoto J., Omote K., Namiki A. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons. Neuroscience 2007, 148:560-572.
22. Noguchi K., Ishii S., Shimizu T. Identification of p2y(9)/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. The Journal of Biological Chemistry 2003, 278:25600-25606.
23. Peters C.M., Ghilardi J.R., Keyser C.P., Kubota K., Lindsay T.H., Luger N.M., Mach D.B., Schwei M.J., Sevcik M.A., Mantyh P.W. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Experimental Neurology 2005, 193:85-100.
24. Radeff-Huang J., Seasholtz T.M., Matteo R.G., Brown J.H. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. Journal of Cellular Biochemistry 2004, 92:949-966.
25. Renback K., Inoue M., Ueda H. Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice. Neuroscience Letters 1999, 270:59-61.
26. Rivera R., Chun J. Biological effects of lysophospholipids. Reviews of Physiology, Biochemistry & Pharmacology 2008, 160:25-46.
27. Salo P.T., Theriault E. Number, distribution and neuropeptide content of rat knee joint afferents. Journal of Anatomy 1997, 190:515-522.
28. Schwei M.J., Honore P., Rogers S.D., Salak-Johnson J.L., Finke M.P., Ramnaraine M.L., Clohisy D.R., Mantyh P.W. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. The Journal of Neuroscience 1999, 19:10886-10897.
29. Seijffers R., Allchorne A.J., Woolf C.J. The transcription factor ATF-3 promotes neurite outgrowth. Molecular and Cellular Neurosciences 2006, 32:143-154.
30. Shim B., Kim D.W., Kim B.H., Nam T.S., Leem J.W., Chung J.M. Mechanical and heat sensitization of cutaneous nociceptors in rats with experimental peripheral neuropathy. Neuroscience 2005, 132:193-201.
31. Shortland P.J., Baytug B., Krzyzanowska A., McMahon S.B., Priestley J.V., Averill S. ATF3 expression in L4 dorsal root ganglion neurons after L5 spinal nerve transection. The European Journal of Neuroscience 2006, 23:365-373.
32. Smyth S.S., Cheng H.Y., Miriyala S., Panchatcharam M., Morris A.J. Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochimica et Biophysica Acta 2008, 1781:563-570.
33. Spiegel S., Milstien S. Critical role of acylglycerol kinase in epidermal growth factor-induced mitogenesis of prostate cancer cells. Biochemical Society Transactions 2005, 33:1362-1365.
34. Suzuki R., Morcuende S., Webber M., Hunt S.P., Dickenson A.H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nature Neuroscience 2002, 5:1319-1326.
35. Tsujino H., Kondo E., Fukuoka T., Dai Y., Tokunaga A., Miki K., Yonenobu K., Ochi T., Noguchi K. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury. Molecular and Cellular Neurosciences 2000, 15:170-182.
36. Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacology & Therapeutics 2006, 109:57-77.
37. Ueda H. Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination. Molecular Pain 2008, 4:11.
38. Wei J.Y., Wang Y.H. Effect of CCK pretreatment on the CCK sensitivity of rat polymodal gastric vagal afferent in vitro. American Journal of Physiology. Endocrinology and Metabolism 2000, 279:695-706.
39. Wu G., Ringkamp M., Hartke T.V., Murinson B.B., Campbell J.N., Griffin J.W., Meyer R.A. Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. The Journal of Neuroscience 2001, 21:RC140:1-5.
40. Xu Y., Fang X.J., Casey G., Mills G.B. Lysophospholipids activate ovarian and breast cancer cells. The Biochemical Journal 1995, 309:933-940.
41. Zhang H., Cang C.L., Kawasaki Y., Liang L.L., Zhang Y.Q., Ji R.R., Zhao Z.Q. Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia. The Journal of Neuroscience 2007, 27:12067-12077.
42. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.